VRT.CN - Veritas Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 53.04M
Enterprise Value 32.98M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.92

Trading Information

Stock Price History

Beta (3Y Monthly) 0.87
52-Week Change 3-83.33%
S&P500 52-Week Change 313.58%
52 Week High 31.7000
52 Week Low 30.2000
50-Day Moving Average 30.2360
200-Day Moving Average 30.3413

Share Statistics

Avg Vol (3 month) 35.11k
Avg Vol (10 day) 316.91k
Shares Outstanding 512.16M
Float 11.23M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct. 15, 2019) 435
Short Ratio (Oct. 15, 2019) 40.01
Short % of Float (Oct. 15, 2019) 4N/A
Short % of Shares Outstanding (Oct. 15, 2019) 40.00%
Shares Short (prior month Aug. 15, 2019) 47.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Feb. 11, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr. 30, 2019
Most Recent Quarter (mrq)Jul. 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-81.52%
Return on Equity (ttm)-668.50%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -3.25M
Net Income Avi to Common (ttm)-12.04M
Diluted EPS (ttm)-1.1260
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)57.56k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.09
Book Value Per Share (mrq)-0.06

Cash Flow Statement

Operating Cash Flow (ttm)-964.1k
Levered Free Cash Flow (ttm)1.64M